The extraordinary breakthrough in how ‘killer’ CD8 + T cells – the body’s ‘army of hitmen’ tasked with taking out new viruses – retain memories of virus strains they encounter was published in the prestigious Nature Communications journal this week (May 13).
University of Melbourne’s Associate Professor Katherine Kedzierska explained how the Australia-Sino collaboration began during the first outbreak of the avian-derived H7N9 virus in China in 2013.
That contagion saw 99% of people infected hospitalised, with a 30% mortality rate. Patient zero was an elderly man who caught the virus from a chicken his wife asked him to buy at the local live bird market.
“We’d never seen anything like H7N9,” Associate Professor Kedzierska said. “The virus was infecting more people rapidly and nobody had immunity. Thankfully, we did manage to contain the virus but we knew we had come face-to-face with a potential pandemic that could kill millions of people around the world if the virus became able to spread between humans,” she said.
“After collecting samples from infected patients we found that people who couldn’t make these T cell flu assassins were dying. These findings lead to the potential of moving from vaccines for specific influenza strains toward developing a protection, which is based on T-cells,” she said.
“From the 30% mortality rate in China we knew the clock was ticking on the situation. Had the contagion spread broken out globally, we’re talking about a history-altering event on the Spanish Flu scale. As it turns out, boosting the T cell adaptive memory capacity is our way in,” Associate Prof Kedzierska said.
“Our extraordinary breakthrough could lead to the development of a vaccine component that can protect against all new influenza viruses, with the potential for future development of a one-off universal flu vaccine shot,” she said. “This work will also help clinicians to make early predictions of how well a patient’s immune system will respond to viruses so they can manage early interventions such as artificial ventilation more effectively, particularly in cases where the patient is at risk of dying.”
The Latest on: Flu vaccine
via Google News
The Latest on: Flu vaccine
- SA flu vaccine distribution hits recordon June 24, 2019 at 1:23 am
A record 613,000 flu vaccines have been distributed to South Australian doctors, as the state's horror flu season continues. Nearly 19,000 influenza cases have been reported during the 2019 season ... […]
- SA hits record flu vaccine distributionon June 23, 2019 at 8:49 pm
A record 613,000 flu vaccines have been distributed to South Australian doctors, as the state's horror flu season continues. SA Health's director of communicable diseases Dr Louise Flood said enough ... […]
- Northland senior citizen irate as flu vaccine runs outon June 23, 2019 at 5:34 pm
A senior citizen in Northland who can not access flu vaccine say it's a bit of a joke for the government to advise people to get immunised when there aren't any vaccines available. Christopher Graham ... […]
- 2018 to 2019 influenza season in U.S. was longest in 10 yearson June 21, 2019 at 5:59 am
In the United States, the 2018 to 2019 influenza season was of moderate severity and lasted 21 weeks, according to research published in the June 21 issue of the U.S. Centers for Disease Control ... […]
- A universal flu vaccine could finally be within sighton June 20, 2019 at 3:20 pm
Influenza is a shape-shifter virus that could spark a global pandemic. Researchers at the National Institutes of Health are working to deliver what is referred to as The Holy Grail in the fight: a ... […]
- Influenza vaccination rates among health care workers still short of goalson June 20, 2019 at 12:20 pm
PORTLAND — A new state report shows that although health care worker influenza vaccination rates have increased over seven flu seasons, facilities overall continue to fall short of national goals. ... […]
- Seasonal Influenza Vaccine Market Size, Share, Demand, Opportunity, Outlook, Trends, Revenue, Future Growth Opportunities By 2016-2022on June 20, 2019 at 2:56 am
Jun 20, 2019 (AmericanNewsHour via COMTEX) -- Kenneth Research examined the statistical and analytical approach that is required for the growth of Seasonal Influenza Vaccine Market. The key industrial ... […]
- China Influenza Vaccine Market Industry Analysis Report (2019 - 2025)| Aleph Biomedical, SANOFI, Aimei Hissen, Hualan Bioon June 20, 2019 at 1:09 am
Jun 20, 2019 (Heraldkeeper via COMTEX) -- QY Research has come up with a newly published report on China influenza vaccine market in its database that provides an in-depth analysis of the key market ... […]
- Patent Covering Manufacturing Process of BiondVax's M-001 Universal Flu Vaccine Allowed in USA and Japanon June 18, 2019 at 3:30 am
JERUSALEM, June 18, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), announced today that a patent covering production processes of the Company's M-001 universal influenza ... […]
- Nasal Spray Flu Vaccine Safe for Childrenon June 17, 2019 at 12:56 pm
Children with asthma and recurrent wheezing who received the intranasal live attenuated influenza vaccine (LAIV) did not experience increased lower respiratory events (LREs) compared with children who ... […]
via Bing News